Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAP0010 in asthmatic children (12 months to 8 years)
NCT00697697Phase 3Terminated
- Sponsor
- Allergan
- Start
- Apr 2008
- Primary completion
- Aug 2009
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by Allergan. Started Apr 2008; status: terminated.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00697697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697697.